Exc tr-ext b9+marg >4.0 cm
CPT 11406 covers the surgical removal of a benign (non-cancerous) skin growth or lesion on the trunk, arms, legs, hands, or feet when the removed area is larger than 4.0 centimeters (about 1.6 inches). The procedure includes closing the wound with stitches.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure the excised diameter including margins, not just the visible lesion. Documentation must clearly state 'excised diameter >4.0 cm' to justify 11406 over 11404.
Impact: Difference between 11404 and 11406 reimbursement is approximately $60-80. Inadequate size documentation is the #1 cause of downcoding to lower-paying codes.
Verify anatomical location qualifies for 11400 series. Face, ears, eyelids, nose, lips, and mucous membranes require 11440 series codes, which have different fee schedules.
Impact: Using wrong anatomical series results in automatic denial or incorrect payment. 11446 (face, >4.0cm) reimburses at $436.72, significantly higher than 11406.
When performing multiple excisions, apply modifier 51 to lower-valued procedures or consider billing multiple units with appropriate modifiers. Rank procedures by RVU value.
Impact: Proper sequencing maximizes reimbursement. Billing 11406 first (highest RVU 9.64) then smaller excisions with modifier 51 can preserve $100+ compared to incorrect sequencing.
Document whether procedure was performed in facility or non-facility setting. Bill using appropriate place of service code (11 for office, 22 for outpatient hospital, 24 for ASC).
Impact: Non-facility setting pays $311.82 vs facility $244.22, a difference of $67.60. Incorrect POS code will trigger auto-adjustment to lower rate.
Include pathology report confirming benign nature in documentation. If lesion is later found to be malignant, consider whether re-excision would be separately billable with modifier 58.
Impact: Malignant findings may justify additional procedures during global period. Proper documentation supports medical necessity for any subsequent procedures.
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.